Cannabis advocates across the US have been pressuring the Drug Enforcement Administration (DEA) to reclassify marijuana and acknowledge the plant’s medicinal benefits , and the agency has ultimately responded by backtracking on the issue. The DEA recently created a new drug code for marijuana derivatives like CBD oil, leaving many medicinal users and extract producers in fear of stricter …